New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Nothing can be 'high' in DHA, EPA, ALA

Omega-3 supplements don't increase prostate cancer risk, study shows
FDA finalizes omega-labeling rule.

The U.S. Food and Drug Administration prohibited food and sup makers from claiming that their products are “high” in some omega-3 fatty acids. Why not? Because the agency hasn’t set a baseline level for those acids, according to

In a rule that finalized a proposed rule published back in 2007, the FDA banned certain nutrient content claims for foods containing docosahexaenoic acid, or DHA (one of the 12 ingredients that will change the world), eicosapentaenoic acid, or EPA, and alpha-linolenic acid, or ALA. The rule finalizes a proposed rule the agency published in 2007.

Claims that products are “high in" DHA or EPA, and synonyms such as “rich in" and “excellent source of" are prohibited, the American Herbal Products Association (AHPA) explained in an April 28 alert, reports

The FDA claims that under the federal Food, Drug & Cosmetic Act, nutrient content claims such as “high in” are allowed only for nutrients for which a reference level to which the claim refers has been set. There are not yet any such levels set for DHA, EPA or ALA.

However, a closer reading of the FDA ruling states that Martek's algae-derived ALA is indeed allowed to continue to make "excellent source" and "good source" claims if the product contains 320mg/serving or 160mg/serving, respectively.


Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.